Site updated at Wednesday, 22 June 2016

Living with Dementia

Psychotic Symptoms

Acadia redesigns study on Parkinson’s psychosis drug

Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson’s disease patients, and that it plans to conduct an identical study to win regulatory approval.

The redesigned study will include only patients from North America, and will exclude mildly psychotic patients, Acadia CEO Uli Hacksell said at… Acadia redesigns study on Parkinson’s psychosis drug   

What is dementia?

preparing for appointment1 - bmi2 - pomegranate1 - carl schneider1 - behavioural syndrome1 - brain health1 - dementiaantipsychotic drugs1 - uncategorized1 - amyloid beta precursor protein1 - slower overall movement1 - alzheimer's symptoms2 - behavioural deterioration1 - apoe gene3 - huntington gene1 - apolipoprotein e41 - wernicke's encephalopathy4 - vascular dementia diagnosis1 - biomarkers of alzheimer's disease1 - bradykinesia1 - biomarkers in cerebrospinal fluid1 - dementia in elderly1 - progressive dementia3 - neu11 - wernicke's syndrome10 - apoe genotype1 - ucla1 - dopamine-deficient worms1 - chronic traumatic encephalopathy1 - cognitive decline19 - world alzheimers day1 -